Hyaluronic acid conjugated with tumour microenvironment sensitive peptides were incorporated in PEI and employed for simultaneously blocking CD47 and expressing IL-12 in tumour-associated macrophages through CRISPR-Cas9 editing, thereby reversing their tumour protective role and activating other immune components [107]. Here, CD47 is linked to neoplasm.